Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles
Mohammad‐Javad Sanaei, Ayda Baghery Saghchy Khorasani, Atieh Pourbagheri‐Sigaroodi, et al.
Journal of Cellular Physiology (2021) Vol. 237, Iss. 3, pp. 1720-1752
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles
Mohammad‐Javad Sanaei, Sara Razi, Atieh Pourbagheri‐Sigaroodi, et al.
Translational Oncology (2022) Vol. 18, pp. 101364-101364
Open Access | Times Cited: 125
Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutant colorectal cancer
Hao Chen, Qinqin Qi, Nan Wu, et al.
Redox Biology (2022) Vol. 55, pp. 102426-102426
Open Access | Times Cited: 103
Therapeutic Potential of Bioactive Components from Scutellaria baicalensis Georgi in Inflammatory Bowel Disease and Colorectal Cancer: A Review
Jung Yoon Jang, Eunok Im, Nam Deuk Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1954-1954
Open Access | Times Cited: 33
Phosphoinositide 3-kinase (PI3K) classes: From cell signaling to endocytic recycling and autophagy
Ava Safaroghli‐Azar, Mohammad‐Javad Sanaei, Atieh Pourbagheri‐Sigaroodi, et al.
European Journal of Pharmacology (2023) Vol. 953, pp. 175827-175827
Closed Access | Times Cited: 25
The PI3K/AKT/mTOR signaling pathway in breast cancer: Review of clinical trials and latest advances
Ayda Baghery Saghchy Khorasani, Nasim Hafezi, Mohammad‐Javad Sanaei, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 3
Closed Access | Times Cited: 10
A Comprehensive Review of Nanoparticle-Based Drug Delivery for Modulating PI3K/AKT/mTOR-Mediated Autophagy in Cancer
Md. Ataur Rahman, Maroua Jalouli, Sujay Kumar Bhajan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1868-1868
Open Access | Times Cited: 1
Autophagy in colitis-associated colon cancer: exploring its potential role in reducing initiation and preventing IBD-Related CAC development
Xuanhong Jin, Liangkun You, Jincheng Qiao, et al.
Autophagy (2023) Vol. 20, Iss. 2, pp. 242-258
Open Access | Times Cited: 18
Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling
Najah Albadari, Yang Xie, Wěi Li
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
A novel MTORC2-AKT-ROS axis triggers mitofission and mitophagy-associated execution of colorectal cancer cells upon drug-induced activation of mutant KRAS
Kartini Iskandar, Jonathan Foo, Angeline Qiu Xia Liew, et al.
Autophagy (2024) Vol. 20, Iss. 6, pp. 1418-1441
Open Access | Times Cited: 6
Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer
Yanan Zheng, Siyue Lou, Jun Lu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 6
The Regulatory Functions and the Mechanisms of Long Non-Coding RNAs in Cervical Cancer
Qiwei Yang, Ayman Al‐Hendy
Cells (2022) Vol. 11, Iss. 7, pp. 1149-1149
Open Access | Times Cited: 27
Ribosomal protein L22‐like1 promotes prostate cancer progression by activating PI3K/Akt/mTOR signalling pathway
Xiaoyu Yi, Chao Zhang, Baojie Liu, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 27, Iss. 3, pp. 403-411
Open Access | Times Cited: 15
Inhibitors of the PI3K/AKT/mTOR pathway in human malignancies; trend of current clinical trials
Zeinab Davoodi‐Moghaddam, Farideh Jafari‐Raddani, Mahda Delshad, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 16, pp. 15293-15310
Closed Access | Times Cited: 15
Noncoding RNAs in the Glycolysis of Ovarian Cancer
Chunmei Zhang, Ning Liu
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
The preventive and therapeutic effects of anthocyanins on colorectal cancer: A comprehensive review based on up-to-date experimental studies
Roberto de Paula do Nascimento, Ana Paula da Fonseca Machado
Food Research International (2023) Vol. 170, pp. 113028-113028
Closed Access | Times Cited: 12
Wighteone, a prenylated flavonoid from licorice, inhibits growth of SW480 colorectal cancer cells by allosteric inhibition of Akt
Xiaofei Chen, Ruili Ma, Weiguo Wu, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118195-118195
Closed Access | Times Cited: 4
Identification of SRC, AKT1 and MAPK3 as Therapeutic Targets of Apigenin and Luteolin in Colorectal and Colon Carcinoma through Network Pharmacology
Kha Wai Hon, Sagnik Nag, B. Stany, et al.
Food Bioscience (2025), pp. 106313-106313
Open Access
The polyphenolic compound, α-conidendrin, exerts anti-colon cancer and anti-angiogenic effects by targeting several signaling molecules
Sayeh Mottaghi, Hassan Abbaszadeh, Armita Valizadeh, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Nanocarrier-based targeting of metabolic pathways for endometrial cancer: Status and future perspectives
Yichao Wang, Siyao Chen, Hong Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115348-115348
Open Access | Times Cited: 10
Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Saba Asadi, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 1-15
Open Access | Times Cited: 3
Revisiting Luteolin Against the Mediators of Human Metastatic Colorectal Carcinoma: A Biomolecular Approach
Ankita Chakraborty, Advaitha Midde, Pritha Chakraborty, et al.
Journal of Cellular Biochemistry (2024) Vol. 126, Iss. 1
Closed Access | Times Cited: 3
Antitumor activity of 5-fluorouracil polymeric nanogel synthesized by gamma radiation on a rat model of colon carcinoma: a proposed mechanism
Omayma AR Abo-Zaid, Fatma SM Moawed, Wael E. M. Barakat, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Targeting autophagy in colorectal cancer: An update on pharmacological small-molecule compounds
Zixiang Li, Wen Si, Wenke Jin, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2373-2385
Closed Access | Times Cited: 13
PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation
Sahar Rezaei, Negin Nikpanjeh, Aryan Rezaee, et al.
European Journal of Pharmacology (2023) Vol. 955, pp. 175909-175909
Closed Access | Times Cited: 7
Pathways and molecules for overcoming immunotolerance in metastatic gastrointestinal tumors
Qixin Gan, Yue Li, Yuejun Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top